(This story is for CNBC Pro subscribers only.)
JPMorgan said Monday's surprise vaccine news is setting the stock market up for big gains next year, seeing the potential for S&P 500 to surge as much as 24% by the end of 2021.
"The equity market is facing one of the best backdrops for sustained gains in years. After a prolonged period of elevated risks (global trade war, COVID-19 pandemic, US election uncertainty, etc.), the outlook is significantly clearing up, especially with news of a highly effective COVID-19 vaccine," Dubravko Lakos-Bujas, chief U.S. equity strategist at JPMorgan, said in a note on Monday.